Research Feeds

View All
Characterizing the gut microbiota in females with infertility and preliminary results of a water-soluble dietary fiber intervention study A prebiotic dietary pilot intervention restores faecal metabolites and may be neuroprotective in Parkinson’s Disease Diagnosis of the menopause: NICE guidance and quality standards Causes of Death in End-Stage Kidney Disease: Comparison Between the United States Renal Data System and a Large Integrated Health Care System Factors affecting the absorption and excretion of lead in the rat Factors associated with age at menarche, menstrual knowledge, and hygiene practices among schoolgirls in Sharjah, UAE Cadmium transport in blood serum The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic Structured Exercise Benefits in Euthyroid Graves’ Disease: Improved Capacity, Fatigue, and Relapse Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease A Pilot Microbiota Study in Parkinson’s Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models Dysbiosis of the Saliva Microbiome in Patients With Polycystic Ovary Syndrome Integrated Microbiome and Host Transcriptome Profiles Link Parkinson’s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain Gut microbiota modulation: a narrative review on a novel strategy for prevention and alleviation of ovarian aging Long-term postmenopausal hormone therapy and endometrial cancer
microbiome signatures definitions

Inductively Coupled Plasma Mass Spectrometry (ICP-MS) is capable of detecting and quantifying elements at parts-per-trillion (ppt) levels. The technique links environmental, clinical, and molecular microbiology by revealing how essential and toxic metals shape community structure and function.

Inductively Coupled Plasma Mass Spectrometry (ICP-MS)

Researched by:

  • Karen Pendergrass ID
    Karen Pendergrass

    User avatarKaren Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

    Read More

December 3, 2025

OverviewInductively Coupled Plasma Mass Spectrometry (ICP-MS) is an analytical technique used to determine the elemental composition of a sample by ionizing the sample with an inductively coupled plasma and then measuring the mass-to-charge ratio of the ions. ICP-MS is a highly sensitive method, capable of detecting elements at trace and ultra-trace levels, making it valuable in […]

research-feed Research feed

Researched by:

  • Karen Pendergrass ID
    Karen Pendergrass

    User avatarKaren Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

    Read More

Last Updated: 2025-12-03

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

See full history

Karen Pendergrass

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

Overview

Inductively Coupled Plasma Mass Spectrometry (ICP-MS) is an analytical technique used to determine the elemental composition of a sample by ionizing the sample with an inductively coupled plasma and then measuring the mass-to-charge ratio of the ions. ICP-MS is a highly sensitive method, capable of detecting elements at trace and ultra-trace levels, making it valuable in various fields like environmental monitoring, geochemistry, materials science, and metallomic signature characterizations for various conditions, including Alzheimer’s dementia, and Parkinson’s disease.

Detection

ICP-MS is known for detecting very low concentrations of elements, often at the parts-per-trillion (ppt) level or even parts-per-quadrillion (ppq). It can simultaneously detect multiple elements in a single measurement. ICP-MS can also be used to determine the isotopic composition of elements, which can be valuable in various applications, including geochemistry and environmental studies. 

Analytical purpose of ICP-MS in microbiome studies

Inductively Coupled Plasma Mass Spectrometry (ICP-MS) offers quantitative, multi-element and isotopic profiling of toxic metals, metalloids and selected non-metal elements in complex biological matrices (faeces, soils, culture broths, host tissues). Applications include:


ApplicationExample outputsRelevance
Metallome characterisationµg kg⁻¹ dry-weight concentrations of >70 elementsNutrient limitation, metal-driven community shifts
Heavy-metal exposureCd, Pb, Hg, As at ng g⁻¹ levelsEcotoxicology, urban microbiome surveillance
Stable-isotope tracing⁵⁷Fe / ⁵⁶Fe, ⁷⁰Zn / ⁶⁴Zn ratiosNutrient flux, trophic interactions

Research Feed

Metallomic signatures of brain tissues distinguishes between cases of dementia with Lewy bodies, Alzheimer’s disease, and Parkinson’s disease dementia
June 26, 2024
/
Metallomic Signatures
Metallomic Signatures

Did you know?
Metallomic signatures can reveal hidden drivers of disease by mapping how trace metals like nickel, iron, and cadmium shape microbial behavior and immune responses. These signatures not only help identify toxic exposures but also spotlight metal-dependent pathogens, offering new targets for precision-guided therapies.

Alias iure reprehenderit aut accusantium. Molestiae dolore suscipit. Necessitatibus eum quaerat. Repudiandae suscipit quo necessitatibus. Voluptatibus ullam nulla temporibus nobis. Atque eaque sed totam est assumenda. Porro modi soluta consequuntur veritatis excepturi minus delectus reprehenderit est. Eveniet labore ut quas minima aliquid quibusdam. Vitae possimus fuga praesentium eveniet debitis exercitationem deleniti.

Create a free account to unlock this study summary.

Microbiome Insiders can read two study summaries for any topic on Microbiome.

(Get started with your free account)

Update History

2025-08-01 07:40:31

Inductively Coupled Plasma Mass Spectrometry (ICP-MS) major

published

Metallomic Signatures

A metallomic signature is the condition-specific profile of trace metals and metal-binding molecules that reflects disrupted metal homeostasis.

Parkinson’s Disease

Parkinson’s disease is increasingly recognized as a systemic disorder involving coordinated disturbances across the gut–brain axis, rather than a condition confined to dopaminergic neurodegeneration alone. Converging evidence implicates gut dysbiosis, altered microbial metabolites, impaired intestinal barrier integrity, and metal dyshomeostasis as upstream drivers of neuroinflammation and alpha-synuclein pathology. These interconnected microbiome, metabolomic, and metallomic signals provide a mechanistic framework for understanding disease initiation, progression, and therapeutic targeting beyond the central nervous system.

Parkinson’s Disease

Parkinson’s disease is increasingly recognized as a systemic disorder involving coordinated disturbances across the gut–brain axis, rather than a condition confined to dopaminergic neurodegeneration alone. Converging evidence implicates gut dysbiosis, altered microbial metabolites, impaired intestinal barrier integrity, and metal dyshomeostasis as upstream drivers of neuroinflammation and alpha-synuclein pathology. These interconnected microbiome, metabolomic, and metallomic signals provide a mechanistic framework for understanding disease initiation, progression, and therapeutic targeting beyond the central nervous system.

Metallomic Signatures

A metallomic signature is the condition-specific profile of trace metals and metal-binding molecules that reflects disrupted metal homeostasis.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.